Neuropsychiatric comorbidity among adolescents with psoriasis
Summary Psoriasis is a common skin disease, typically presenting as a red scaly rash. In mild cases it can be treated with creams, while in patients with so called “moderate to severe psoriasis”, where it is extensive or cannot be controlled with creams only, a systemic treatment, such as pills and...
Gespeichert in:
Veröffentlicht in: | British journal of dermatology (1951) 2018-04, Vol.178 (4), p.e301-e301 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e301 |
---|---|
container_issue | 4 |
container_start_page | e301 |
container_title | British journal of dermatology (1951) |
container_volume | 178 |
creator | Galili, E. Barzilai, A. Shreberk‐Hassidim, R. Merdler, I. Caspi, T. Astman, N. |
description | Summary
Psoriasis is a common skin disease, typically presenting as a red scaly rash. In mild cases it can be treated with creams, while in patients with so called “moderate to severe psoriasis”, where it is extensive or cannot be controlled with creams only, a systemic treatment, such as pills and phototherapy, is necessary. Psoriasis affects about 2% of adults. It commonly develops in adulthood, but can also be seen in children and adolescents. As might be expected, psoriasis may be physically and emotionally disabling. Growing data suggests that psoriasis patients are at risk of suffering from multiple medical conditions, including mental health disorders (e.g depression) and neurological disorders (e.g migraine). This study, from Israel, aimed to find out whether psoriasis carries a risk of suffering from mental health and neurological disorders, focusing on adolescents, an age group which was previously less studied for these conditions. Data were retrieved from records of recruits evaluated for military service. The study included 1746 and 1366 adolescents (aged 16 to 18) with mild and moderate to severe psoriasis, respectively, and compared them to 884653 healthy adolescents. Differences in the prevalence of the following medical conditions were found between adolescents with moderate to severe psoriasis and healthy adolescents: Overall chronic headaches (8.1% vs. 3.4%), intermediate frequency migraine (4.8% vs. 1.6%), low frequency migraine and non‐migraine headaches (3.4% vs. 1.8%), anxiety (2.1% vs. 0.7%) and social adjustment disabilities (7.5% vs. 4.2%). Interestingly, mild psoriasis was not shown to carry a risk for these conditions. The authors conclude that adolescents with psoriasis, especially those with a moderate to severe disease, are at risk of neurological and mental health disorders. The authors call for physicians’ awareness of these conditions, alongside the need for psychological counselling.
Linked Article: Galili et al. Br J Dermatol 2018; 178:910–916 |
doi_str_mv | 10.1111/bjd.16510 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2026434808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2026434808</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1020-49be78217e99a55b393a664b2f38122265a8fcf6ab8161e617dee215eaa20e163</originalsourceid><addsrcrecordid>eNp1kD1PwzAURS0EEqUw8A8iMTGkvGfHTjIwQPlWBQvMluO8UFdtHexUVf49gbDylruce590GDtHmOFwV9WqnqGSCAdsgkLJlKMQh2wCAHkKpRLH7CTGFQAKkDBh16-0C76NvV060wVnE-s3PlSudl2fmI3ffiam9muKlrZdTPauWyZt9MGZ6OIpO2rMOtLZX07Zx8P9-_wpXbw9Ps9vFqlF4JBmZUV5wTGnsjRSVqIURqms4o0okHOupCka2yhTFaiQFOY1EUdJxnAgVGLKLsbdNvivHcVOr_wubIeXmgNXmcgKKAbqcqRs8DEGanQb3MaEXiPoHzt6sKN_7Qzs1cju3Zr6_0F9-3I3Nr4Bpmhllg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2026434808</pqid></control><display><type>article</type><title>Neuropsychiatric comorbidity among adolescents with psoriasis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Wiley Online Library All Journals</source><creator>Galili, E. ; Barzilai, A. ; Shreberk‐Hassidim, R. ; Merdler, I. ; Caspi, T. ; Astman, N.</creator><creatorcontrib>Galili, E. ; Barzilai, A. ; Shreberk‐Hassidim, R. ; Merdler, I. ; Caspi, T. ; Astman, N.</creatorcontrib><description>Summary
Psoriasis is a common skin disease, typically presenting as a red scaly rash. In mild cases it can be treated with creams, while in patients with so called “moderate to severe psoriasis”, where it is extensive or cannot be controlled with creams only, a systemic treatment, such as pills and phototherapy, is necessary. Psoriasis affects about 2% of adults. It commonly develops in adulthood, but can also be seen in children and adolescents. As might be expected, psoriasis may be physically and emotionally disabling. Growing data suggests that psoriasis patients are at risk of suffering from multiple medical conditions, including mental health disorders (e.g depression) and neurological disorders (e.g migraine). This study, from Israel, aimed to find out whether psoriasis carries a risk of suffering from mental health and neurological disorders, focusing on adolescents, an age group which was previously less studied for these conditions. Data were retrieved from records of recruits evaluated for military service. The study included 1746 and 1366 adolescents (aged 16 to 18) with mild and moderate to severe psoriasis, respectively, and compared them to 884653 healthy adolescents. Differences in the prevalence of the following medical conditions were found between adolescents with moderate to severe psoriasis and healthy adolescents: Overall chronic headaches (8.1% vs. 3.4%), intermediate frequency migraine (4.8% vs. 1.6%), low frequency migraine and non‐migraine headaches (3.4% vs. 1.8%), anxiety (2.1% vs. 0.7%) and social adjustment disabilities (7.5% vs. 4.2%). Interestingly, mild psoriasis was not shown to carry a risk for these conditions. The authors conclude that adolescents with psoriasis, especially those with a moderate to severe disease, are at risk of neurological and mental health disorders. The authors call for physicians’ awareness of these conditions, alongside the need for psychological counselling.
Linked Article: Galili et al. Br J Dermatol 2018; 178:910–916</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.16510</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adolescents ; Anxiety ; Children ; Headache ; Mental disorders ; Mental health ; Migraine ; Neurological diseases ; Neurological disorders ; Patients ; Phototherapy ; Psoriasis ; Skin diseases ; Social interactions ; Teenagers</subject><ispartof>British journal of dermatology (1951), 2018-04, Vol.178 (4), p.e301-e301</ispartof><rights>2018 British Association of Dermatologists</rights><rights>Copyright © 2018 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.16510$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.16510$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Galili, E.</creatorcontrib><creatorcontrib>Barzilai, A.</creatorcontrib><creatorcontrib>Shreberk‐Hassidim, R.</creatorcontrib><creatorcontrib>Merdler, I.</creatorcontrib><creatorcontrib>Caspi, T.</creatorcontrib><creatorcontrib>Astman, N.</creatorcontrib><title>Neuropsychiatric comorbidity among adolescents with psoriasis</title><title>British journal of dermatology (1951)</title><description>Summary
Psoriasis is a common skin disease, typically presenting as a red scaly rash. In mild cases it can be treated with creams, while in patients with so called “moderate to severe psoriasis”, where it is extensive or cannot be controlled with creams only, a systemic treatment, such as pills and phototherapy, is necessary. Psoriasis affects about 2% of adults. It commonly develops in adulthood, but can also be seen in children and adolescents. As might be expected, psoriasis may be physically and emotionally disabling. Growing data suggests that psoriasis patients are at risk of suffering from multiple medical conditions, including mental health disorders (e.g depression) and neurological disorders (e.g migraine). This study, from Israel, aimed to find out whether psoriasis carries a risk of suffering from mental health and neurological disorders, focusing on adolescents, an age group which was previously less studied for these conditions. Data were retrieved from records of recruits evaluated for military service. The study included 1746 and 1366 adolescents (aged 16 to 18) with mild and moderate to severe psoriasis, respectively, and compared them to 884653 healthy adolescents. Differences in the prevalence of the following medical conditions were found between adolescents with moderate to severe psoriasis and healthy adolescents: Overall chronic headaches (8.1% vs. 3.4%), intermediate frequency migraine (4.8% vs. 1.6%), low frequency migraine and non‐migraine headaches (3.4% vs. 1.8%), anxiety (2.1% vs. 0.7%) and social adjustment disabilities (7.5% vs. 4.2%). Interestingly, mild psoriasis was not shown to carry a risk for these conditions. The authors conclude that adolescents with psoriasis, especially those with a moderate to severe disease, are at risk of neurological and mental health disorders. The authors call for physicians’ awareness of these conditions, alongside the need for psychological counselling.
Linked Article: Galili et al. Br J Dermatol 2018; 178:910–916</description><subject>Adolescents</subject><subject>Anxiety</subject><subject>Children</subject><subject>Headache</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Migraine</subject><subject>Neurological diseases</subject><subject>Neurological disorders</subject><subject>Patients</subject><subject>Phototherapy</subject><subject>Psoriasis</subject><subject>Skin diseases</subject><subject>Social interactions</subject><subject>Teenagers</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kD1PwzAURS0EEqUw8A8iMTGkvGfHTjIwQPlWBQvMluO8UFdtHexUVf49gbDylruce590GDtHmOFwV9WqnqGSCAdsgkLJlKMQh2wCAHkKpRLH7CTGFQAKkDBh16-0C76NvV060wVnE-s3PlSudl2fmI3ffiam9muKlrZdTPauWyZt9MGZ6OIpO2rMOtLZX07Zx8P9-_wpXbw9Ps9vFqlF4JBmZUV5wTGnsjRSVqIURqms4o0okHOupCka2yhTFaiQFOY1EUdJxnAgVGLKLsbdNvivHcVOr_wubIeXmgNXmcgKKAbqcqRs8DEGanQb3MaEXiPoHzt6sKN_7Qzs1cju3Zr6_0F9-3I3Nr4Bpmhllg</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Galili, E.</creator><creator>Barzilai, A.</creator><creator>Shreberk‐Hassidim, R.</creator><creator>Merdler, I.</creator><creator>Caspi, T.</creator><creator>Astman, N.</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>201804</creationdate><title>Neuropsychiatric comorbidity among adolescents with psoriasis</title><author>Galili, E. ; Barzilai, A. ; Shreberk‐Hassidim, R. ; Merdler, I. ; Caspi, T. ; Astman, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1020-49be78217e99a55b393a664b2f38122265a8fcf6ab8161e617dee215eaa20e163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescents</topic><topic>Anxiety</topic><topic>Children</topic><topic>Headache</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Migraine</topic><topic>Neurological diseases</topic><topic>Neurological disorders</topic><topic>Patients</topic><topic>Phototherapy</topic><topic>Psoriasis</topic><topic>Skin diseases</topic><topic>Social interactions</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galili, E.</creatorcontrib><creatorcontrib>Barzilai, A.</creatorcontrib><creatorcontrib>Shreberk‐Hassidim, R.</creatorcontrib><creatorcontrib>Merdler, I.</creatorcontrib><creatorcontrib>Caspi, T.</creatorcontrib><creatorcontrib>Astman, N.</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galili, E.</au><au>Barzilai, A.</au><au>Shreberk‐Hassidim, R.</au><au>Merdler, I.</au><au>Caspi, T.</au><au>Astman, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuropsychiatric comorbidity among adolescents with psoriasis</atitle><jtitle>British journal of dermatology (1951)</jtitle><date>2018-04</date><risdate>2018</risdate><volume>178</volume><issue>4</issue><spage>e301</spage><epage>e301</epage><pages>e301-e301</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><abstract>Summary
Psoriasis is a common skin disease, typically presenting as a red scaly rash. In mild cases it can be treated with creams, while in patients with so called “moderate to severe psoriasis”, where it is extensive or cannot be controlled with creams only, a systemic treatment, such as pills and phototherapy, is necessary. Psoriasis affects about 2% of adults. It commonly develops in adulthood, but can also be seen in children and adolescents. As might be expected, psoriasis may be physically and emotionally disabling. Growing data suggests that psoriasis patients are at risk of suffering from multiple medical conditions, including mental health disorders (e.g depression) and neurological disorders (e.g migraine). This study, from Israel, aimed to find out whether psoriasis carries a risk of suffering from mental health and neurological disorders, focusing on adolescents, an age group which was previously less studied for these conditions. Data were retrieved from records of recruits evaluated for military service. The study included 1746 and 1366 adolescents (aged 16 to 18) with mild and moderate to severe psoriasis, respectively, and compared them to 884653 healthy adolescents. Differences in the prevalence of the following medical conditions were found between adolescents with moderate to severe psoriasis and healthy adolescents: Overall chronic headaches (8.1% vs. 3.4%), intermediate frequency migraine (4.8% vs. 1.6%), low frequency migraine and non‐migraine headaches (3.4% vs. 1.8%), anxiety (2.1% vs. 0.7%) and social adjustment disabilities (7.5% vs. 4.2%). Interestingly, mild psoriasis was not shown to carry a risk for these conditions. The authors conclude that adolescents with psoriasis, especially those with a moderate to severe disease, are at risk of neurological and mental health disorders. The authors call for physicians’ awareness of these conditions, alongside the need for psychological counselling.
Linked Article: Galili et al. Br J Dermatol 2018; 178:910–916</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><doi>10.1111/bjd.16510</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0963 |
ispartof | British journal of dermatology (1951), 2018-04, Vol.178 (4), p.e301-e301 |
issn | 0007-0963 1365-2133 |
language | eng |
recordid | cdi_proquest_journals_2026434808 |
source | Oxford University Press Journals All Titles (1996-Current); Wiley Online Library All Journals |
subjects | Adolescents Anxiety Children Headache Mental disorders Mental health Migraine Neurological diseases Neurological disorders Patients Phototherapy Psoriasis Skin diseases Social interactions Teenagers |
title | Neuropsychiatric comorbidity among adolescents with psoriasis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A14%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuropsychiatric%20comorbidity%20among%20adolescents%20with%20psoriasis&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Galili,%20E.&rft.date=2018-04&rft.volume=178&rft.issue=4&rft.spage=e301&rft.epage=e301&rft.pages=e301-e301&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.16510&rft_dat=%3Cproquest_cross%3E2026434808%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2026434808&rft_id=info:pmid/&rfr_iscdi=true |